Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.

By B. Schmidt, Peter G. Davis, D. Moddemann, A. Ohlsson, R. Roberts, S. Saigal, A. Solimano, M. Vincer, L. Wright. New England Journal of Medicine, 2001

649 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/28f52ff0f10490af6566382eabbc151760f36e19

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Schmidt
2. R. Roberts
3. E. Asztalos
4. C. Robertson
5. R. Sauve
6. M. Whitfield

Citations in the corpus

• Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. (2003, methodology): “In the TIPP study, the primary composite outcome was death before a corrected age of 18 months or the presence in survivors of 1 or more of the following: cerebral palsy, cognitive delay, hearing loss requiring amplification, and bilateral blindness.(10) The same long-term composite outcome was used”
• Poor Predictive Validity of the Bayley Scales of Infant Development for Cognitive Function of Extremely Low Birth Weight Children at School Age (2005, neutral): “Poor gross motor function (BruininksOserelsky 30), n (%)‡* 26 (93)† 17 (35)† 9 (8)† 6 (75)‡ 8 (23)†‡ 4 (4)†”